Saroja Pharma Industries India Ltd vs Sree Rayalaseema Hi Strength Hypo Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 29, 2026

Key Highlights

The Latest Trading Price of Saroja Pharma Industries India Ltd is ₹ 29.35 as of 25 Mar 15:30 . The P/E Ratio of Saroja Pharma Industries India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Sree Rayalaseema Hi-Strength Hypo Ltd changed from 6.7 on March 2021 to 9.4 on March 2025 . This represents a CAGR of 7.01% over 5 years The Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Sree Rayalaseema Hi-Strength Hypo Ltd changed from ₹ 405.69 crore on March 2021 to ₹ 845.2 crore on March 2025 . This represents a CAGR of 15.81% over 5 years The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sree Rayalaseema Hi-Strength Hypo Ltd for the Dec '25 is ₹ 160.58 crore as compare to the Sep '25 revenue of ₹ 189.49 crore. This represent the decline of -15.26% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sree Rayalaseema Hi-Strength Hypo Ltd for the Dec '25 is ₹ 36.45 crore as compare to the Sep '25 ebitda of ₹ 34.05 crore. This represent the growth of 7.05% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sree Rayalaseema Hi-Strength Hypo Ltd changed from ₹ 18.62 crore to ₹ 23.75 crore over 7 quarters. This represents a CAGR of 14.92% The Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sree Rayalaseema Hi-Strength Hypo Ltd changed from 8.5 % on March 2021 to 5.55 % on March 2025 . This represents a CAGR of -8.17% over 5 years .

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

About Sree Rayalaseema Hi-Strength Hypo Ltd

Sree Rayalaseema Hi-Strength Hypo Limited was incorporated in March, 2005.
The Company is the leading producer of Calcium Hypo Chloride, Stable Bleaching Powder, Sulphuric Acid and Other Chemicals. Sree Rayalaseema Hi-Strength Hypo, the torch bearer of the conglomerate, is the only Indian manufacturer of Calcium Hypochlorite, and one of the very few in the world.
A state-of-the-art sodium process technology developed through in-house R&D efforts helps the company in manufacturing the product with a chlorine content of 65% to 70%. The business of manufacturing of industrial chemicals was vested in the Company effective on 1st April, 2005 through Scheme of Arrangement in June, 2006 and generation of Wind Energy in 2008. The Company products can be broadly classified under Inorganic chemicals.

FAQs for the comparison of Saroja Pharma Industries India Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd

Which company has a larger market capitalization, Saroja Pharma Industries India Ltd or Sree Rayalaseema Hi-Strength Hypo Ltd?

Market cap of Saroja Pharma Industries India Ltd is 11 Cr while Market cap of Sree Rayalaseema Hi-Strength Hypo Ltd is 696 Cr

What are the key factors driving the stock performance of Saroja Pharma Industries India Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd?

The stock performance of Saroja Pharma Industries India Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Saroja Pharma Industries India Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd?

As of March 29, 2026, the Saroja Pharma Industries India Ltd stock price is INR ₹29.35. On the other hand, Sree Rayalaseema Hi-Strength Hypo Ltd stock price is INR ₹406.0.

How do dividend payouts of Saroja Pharma Industries India Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd compare?

To compare the dividend payouts of Saroja Pharma Industries India Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.